The effectiveness of 1-epinephrine and 1-norepinephrine in enhancing ventricular vulnerability has l)een compared in twelve dogs by obtaining fibrillation thresholds for single test stimuli. Both agents produce similar increases in vulnerability immediately following injection, and similar decreases in vulnerability at longer intervals following drug administration. These changes in vulnerability occur simultaneously with alterations of the same direction in resting excitability, and are dose-related. It is concluded that these agents have qualitatively and quantitatively similar effects on ventricular vulnerability.
T HE well known propensity of epinephrine to induce ventricular arrhythmias and fibrillation is a deterrent to the use of this drug in a variety of conditions accompanied by circulator}' collapse. Usually the arrhythmias occur within the first minute or two following injection; after longer periods, the onset of ventricular fibrillation is rare. Although these disturbances of rhythm may follow epinephrine administration even when no cardiac abnormality is present, heart disease and certain therapeutic and anesthetic agents increase the likelihood of their occurrence. 1 Recently, numerous clinical studies have demonstrated that dilute nor-epinephrine can l>e employed with apparent impunity in situations where the use of epinephrine would be accompanied by considerable risk 2 . These findings suggest either that there is some basic difference between the effect of the two agents on cardiac excitability or that the more careful control of the concentration and injection rate of norepinephrine has resulted in a greater margin of safety.
There are many examples of tissues that do react differently to these two sympathomimetic drugs 34 ' 6 ; on the other hand, a recent comparison of their effects on certain parameters of the excitability of the dog heart" revealed no qualitative or quantitative difference between them. The effect of both epinephrine and norepinephrine on the resting excitability of cardiac muscle is biphasic: a one to two minute early period of increased excitability during which thresholds are lowered 25-50 per cent is followed by a ten to thirty minute period when excitability is depressed below resting levels. Furthermore, the extent of these changes is intimately related to the dose and to the rate of administration.
The present study concerns the effect of epinephrine and norepinephrine on vulnerability to fibrillation. The object of the work was twofold: first, to compare the potency of the two agents with respect to enhancing ventricular vulnerability, and second, to determine the relationship between the changes in resting excitability and vulnerability that result from administering the two amines.
METHODS
Twelve mongrel dogs weighing from 7-15 Kg. were studied. Each animal was anesthetized with intravenous Pentobarbital sodium, the chest opened by means of a mid-sternal incision, and silver testing, driving and recording electrodes attached to the right atrium and ventricle. The techniques employed have previously been described in detail. 7 '* After the S-A node had been inactivated by crushing, the sternal margins were approximated and the heart driven at a constant rate by stimuli applied through the auricular electrodes. A rapid driven rate was selected, usually 240 beats/min., to prevent ventricular escape following injection of the pressor amines. Both vagus nerves were sectioned to obviate the occurrence of A-V block.
Rectangular test stimuli of known strength and 140
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duration were delivered to the right ventricle in measuring thresholds for single extrasystoles at selected intervals of the entire cardiac cycle. In a similar manner, the minimum thresholds for either multiple ventricular extrasystoles or for fibrillation were obtained throughout the vulnerable period.*' 10 Defibrillation, when necessary, was accomplished by means of a brief burst of 60 cycle current applied directly to the ventricle through large padded electrodes; in most instances, a current of two to three amperes was allowed to flow for a single period lasting 0.6 seconds. Since fibrillation rarely lasted longer than 45 seconds, cardiac massage was not necessary. In most cases it was possible to resume testing within less than five minutes following defibrillation without encountering any significant change in excitability. 10 The chloride salts of 1-epinephrine and 1-norepinephrine, at a dilution of 1:25,000, were injected into the external jugular vein by means of a mechanically driven syringe. The injection rate of these solutions was varied in different experiments from 0.5 to 4.5 ml. per minute, and the total volume injected varied from 0.5 to 10 ml. An interval of one to one and one half hours elapsed between injections in most experiments.
RESULTS
Tlie Ventricular Strength-hiterval Curve ami the Vulnerable Period. As revealed by earlier studies", the strength-interval curve depicting the time course for the recovery of excitability in ventricular muscle describes a rapid return of excitability toward normal during the early part of the relative refractor}' period, a transient regression or dip just prior to the end of the total refractory period, and a constant, low threshold during diastole ( fig. 1 ). Attimesabrief period of supernormality follows immediately after the end of the total refractory period. If a stimulus applied during the vulnerable period is progressively increased in strength above that value required for eliciting a single response, first multiple extrasystoles and then fibrillation is produced. This period of vulnerability always lies within the relative refractory period and most often overlies the dip of the strength-interval curve ( fig. 1 ). Since it has been demonstrated that the production of multiple extrasystoles has the same significance as the production of fibrillation, 8 ' 10 the boundaries of the vulnerable period and the thresholds within it were identified by means of stimuli just adequate to produce the former response whenever possible; in this manner the delay necessitated by defibrillation was largely avoided. In this paper, then, the term "fibrillation threshold" refers to the production of either multiple responses or fibrillation. contribute to the understanding of the results. Determining a single fibrillation threshold required from 15 to 30 seconds. Since, as has been previously demonstrated 8 , excitability changes vary rapidly during injection of either epinephrine or nor-epinephrine, it was impossible during the first one to two minutes following the start of injection to outline the entire vulnerable period during an interval when the level of resting excitability remained constant. For these reasons, this program was adopted: following the start of an injection, the level of resting excitability was tested every five seconds. As soon as a rapid increase in excitability appeared, the fibrillation threshold at the most vulnerable interval of the cycle was obtained. A check was then made of the level of resting excitability, and determination of the INTERVAL msec Fia. 2. Insert demonstrates relationship of vulnerable period to strength-interval curve under control conditions. Graph depicts the effect of 1-epinephrine on fibrillation thresholds: 1 = just prior to, 2 -1 minute, 3 -2 minutes and 4 = 5 minutes following injection of 2.5 ml. of a 1:25,000 dilution within a 2.5 minute interval. lowest fibrillation threshold was repeated. After two to three minutes, when the changes in excitability became more gradual, it was again possible to outline the entire vulnerable period whenever desired.
A second major difficulty was as follows: The graph depicting the boundaries of the -vulnerable period inscribes an acute angle with the apex at the lowest threshold. Because of this pattern and because both amines at times produced a slight shift in the position of the vulnerable period in the cardiac cycle, it was quite likely that during the period of rapid change in excitability the lowest threshold would be missed. Thus the values obtained during the first few minutes following the start of injection may have been too high. Finally, in some instances, a brief run of ventricular tachycardia occurred immediately after the start of injection; this prevented any threshold determinations until the drive stimulus regained dominance of the cardiac rhythm. 
Tlic Effects of l-Epinephrine on Vulnerability.
The injection of l-epinephrine had a consistent and profound effect on the vulnerability of the ventricle to single test stimuli. As seen in figure 2, when a 1:25,000 solution was injected at a rate of 1.25 ml. per minute, the minimum fibrillation thresholds were often lowered to levels only slightly above those required for eliciting a single response. Lowest thresholds were obtained from one to three minutes after the start of injection. Subsequently, greater difficulty in producing fibrillation was encountered, even to the extent that the heart became less vulnerable than before drug administration. In most animals this period of lessened vulnerability persisted from 10 to 30 minutes prior to the return to control values.
With slower rates of injection (0.5 to 0.7 ml. per minute), although the early enhancement of vulnerability was reproduced, the second phase, that of diminished vulnerability, was greatly decreased or absent. Of some interest was the observation that, even when the injection period was prolonged up to ten minutes, the phase of lowered fibrillation thresholds lasted only two to three minutes. A similarly transient change characterizes the effect of epinephrine on resting excitability 6 .
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The Effect of l-Nor-Epinephrine on Vulnerability. L-norepinephrine, when injected in the same concentration and at the same rate as epinephrine, produced similar changes in vulnerability. As seen in figure 3, fibrillation thresholds were lowered markedly immediately following the start of injection and, after two to three minutes, returned to control values. With the more rapid rates of injection, a period of decreased vulnerability followed, just as in the case of epinephrine.
With both amines, the effect of a single dose was quite constant in a given animal. Even repeated administration produced no permanent change in the control values ( fig. 4  and 6 ).
Relationship belioeen Fibrillation Thresholds and Resting Excitability. In most experiments there was a close temporal correspondence between the effect of the sympathomimetic amine on the level of resting excitability and on the fibrillation thresholds. As demonstrated in figure 5 and 6 and table 1, the period of maximum vulnerability corresponded closely with the maximum lowering of diastolic thresholds. Similarly, the period of decreased vulnerability was more or less coexistent with the elevation of diastolic thresholds above control values. The correlation between the magnitude of change in the fibrillation and diastolic thresh-olds was less exact. The per cent change in each of these variables at different times after injection is shown in table 1. While in some cases the magnitude of change in both is remarkably similar, in other instances a large change in one is accompanied by a minor variation in the other. It is likely, however, that these results are at least in part due to the testing technique since, as stated earlier, the simultaneous determination of the fibrillation and diastolic thresholds was impossible. Thus, at least during the time when excitability was changing rapidly, similar conditions in the myocardium may not have obtained at the time the two measurements were made.
Effect of Rate of Injection. Earlier studies of the effect of epinephrine and norepinephrine on the excitability of the dog ventricle* demonstrated that the change in diastolic threshold produced by these drugs was dependent upon the rate of injection of the test solution. Slow injection produced a slight fall in threshold with a prompt return to normal; more rapid administration gave rise to a more pronounced fall followed by a persistent rise to levels well above the control values. It was of interest to attempt to determine if this same relationship obtained in the case of fibrillation thiesholds and a number of experiments were performed with this objective. However, the very limited duration of the early drug effect and the difficulty encountered in measuring the lowest fibrillation threshold made an exact quantitative relationship between rate of injection and magnitude of effect impossible to obtain. It was possible, however, to establish that more rapid injection of either epinephrine or norepinephrine gave rise to a greater lowering of the fibrillation thresholds than did Jess rapid injections. In a number of experiments with both agents sufficiently slow injection failed to produce any detectable increase in vulnerability. In addition, the phase of increased resistance to fibrillation rarely followed slow administration and almost always accompanied the elevation of diastolic thresholds that resulted from rapid injection.
Comparison of l-Epinephrine am] l-Nor-Epinephrine. In a number of experiments the effectiveness of similar doses of both epinephrine and nor-epinephrine were compared in the same animal. As shown in figure 6, both sympathomimetic drugs had similar qualitative and quantitative effects with respect to both the early phase of enhanced vulnerability and the subsequent phase of elevated fibrillation thresholds. Furthermore, there was no difference between these amines either in the frequency with which fibrillation followed their use or in the ease of defibrillation by means of countershock.
DISCUSSION
The results of this investigation have demonstrated that there is little or no difference between epinephrine and norepinephrine with respect to their ability to increase the vulnerability of the dog ventricle to fibrillation. Furthermore, the evidence suggests that not only is the reported greater safety of norepinephrine due to the fact that in clinical practice it has most frequently been injected in high dilution, but also that either agent, if injected at sufficiently slow rates, will give rise to little, if any, enhanced vulnerability. This observation suggests that the differences found in clinical practice are attributed to unequal rates of injection rather than to specific pharmacologic attributes. Both amines typically produce only a brief lowering of the ventricular fibrillation thresholds. This correlates with the observation that this arrhythmia most often appears during the first minute after injection in both normal and sensitized hearts.
Of some interest are the simultaneous changes in the fibrillation and diastolic thresholds. The phase of enhanced vulnerability coincides with an increase, and the phase of depressed vulnerability with a decrease in resting excitability. In view of the fact that the doses of epinephrine and nor-epinephrine employed produce only slight changes in the duration of refractoriness, and since both refractory periods and conduction velocity return to normal often before the fibrillatiou thresholds,' it is tempting to conclude that it is the \$ve\ of resting excitability which is most directly related to the degree of vulenrability. Similar conclusions have been suggested by others. On the other hand, it has been demonstrated that vagal activity produces a great increase in the vulnerability of the dog's auricle in the absence of any change in diastolic thresholds and in the presence of a great reduction in the duration of the total refractory period." Moreover, hypothermia, which prolongs refractoriness, slows conduction, and elevates thresholds, also greatly increases the incidence of ventricular fibrillation. Thus, circumstances exist in which enhanced vulnerability is associated with either no change or even a decrease in resting excitability. If all of these observations are considered, it cannot be concluded, therefore, that the changes in excitability and in fibrillation thresholds are causally related. Rather, it appeal's that these two parameters reflect simultaneous but probably independent effects of these drugs on the basic processes regulating tissue excitability.
SUMMARY
The effects of injections of 1-epinephrine and 1-norepinephriiie on the vulnerability of the dog ventricle have been compared. The two drugs produced changes which were qualitatively and quantitatively similar. Both caused a brief enhancement and then a long-lasting and less marked depression of vulnerability. These effects were dose-related and they coincided with changes of similar direction in the level of resting excitability.
